• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    NATCO API unit gets 7 observations from FDA Read more

    ET PHARMA

    US Regulator Classifies Natco Pharma`s Kothur Unit as `Voluntary

    ECONOMICTIMES

    USFDA issues Form 483 with 7 observations to Natco Hyderabad

    ECONOMICTIMES

    USFDA inspection at API manufacturing plant located in Mekaguda

    INDPHARMAPOST

    Delhi HC tells Natco Pharma to halt Risdiplam launch

    ECONOMICTIMES

    USFDA pulls up Natco Pharma for several violations at Telangana plant

    BUSINESS STANDARD

    FDA hits Natco with warning letter over India facility, suspends product shipments to US

    ENDPTS

    Lupin, Glenmark recall drugs in US market: USFDA

    MONEYCONTROL

    Natco Pharma gets USFDA warning letter for Kothur plant

    BSEINDIA

    Natco Pharma gets warning letter from USFDA for Telangana plant

    ECONOMIC TIMES

    FDA slams Natco Pharma with Form 483 over sanitary, other issues

    FIERCE PHARMA

    Natco Pharma shares down as USFDA issues 8 observations for Hyderabad unit

    MONEY CONTROL

    Natco Pharma Vizag facility gets two USFDA observations

    BUSINESS STANDARD

    Natco Pharma gets EIR from USFDA for Telangana facility

    ECONOMIC TIMES

    Natco Pharma facility completes USFDA inspection

    THE HINDU

    Sun Pharma chief, Dr. Reddy`s, Natco and more—FiercePharmaAsia

    FIERCE PHARMA

    USFDA issues 6 observations to Natco Pharma`s API facility near Hyderabad

    ECONOMICTIMES

    Natco Pharma receives FDA report for plant in Telangana

    MONEYCONTROL

    USFDA completes Chennai facility audit with zero observations: Natco Pharma

    BUSINESS STANDARD

    Natco Pharma gets USFDA observations on 2 facilities, shares fall

    LIVEMINT

    Natco Pharma gets EIR from USFDA for Kothur facility

    ECONOMIC TIMES

    Natco Brings its Scrappy Style to U.S. with Copaxone, Revlimid Knockoffs

    FIERCE PHARMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.